Context Matters—Why We Need to Change From a One Size Fits all Approach to Made-to-Measure Therapies for Individual Patients With Pancreatic Cancer
Pancreatic cancer is one of the deadliest cancers and remains a major unsolved health problem. While pancreatic ductal adenocarcinoma (PDAC) is associated with driver mutations in only four major genes (KRAS, TP53, SMAD4, and CDKN2A), every tumor differs in its molecular landscape, histology, and pr...
Guardado en:
Autores principales: | Sushmitha Sankarasubramanian, Ulrike Pfohl, Christian R. A. Regenbrecht, Christoph Reinhard, Lena Wedeken |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/16fe49992be043d99450bb2184646f46 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cell Lineage Infidelity in PDAC Progression and Therapy Resistance
por: Antonia Malinova, et al.
Publicado: (2021) -
High expression of WNT7A predicts poor prognosis and promote tumor metastasis in pancreatic ductal adenocarcinoma
por: Dong-jin Wu, et al.
Publicado: (2018) -
Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance
por: Shin-Heng Chiou, et al.
Publicado: (2018) -
Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits
por: Parniyan Maneshi, et al.
Publicado: (2021) -
Deregulation of Transcription Factor Networks Driving Cell Plasticity and Metastasis in Pancreatic Cancer
por: Ruthger van Roey, et al.
Publicado: (2021)